Definitive Contract 75N99225C00002
Award Date
9/18/25
Potential Completion Date
9/17/30
Potential Value
$61M
Federal Agency
National Institutes of Health
Awardee
Tempus AI, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Washington, DC 20005, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Tempus AI, Inc. (doing business as Tempus Labs Inc.) for tumor normal matched genomic testing services. The contract has a ceiling value of $325,119.50 and a performance period through September 25, 2023. Tempus Labs is a technology company specializing in precision medicine and genomic sequencing services. This contract supports the VA's precision oncology initiatives for veteran cancer...
This federal contract award is for TUMOR NORMAL MATCHED GENOMIC TESTING SERVICES, awarded by the U.S. Department of Veterans Affairs (VA) to Tempus AI, Inc., doing business as Tempus Labs Inc. The contract has a ceiling value of $7,989,504.00 and is a firm fixed price delivery order with a performance period through January 27, 2024. Tempus Labs Inc. is the prime contractor and specializes in precision medicine and genomic sequencing services. The company has established itself as a key provider...
This firm fixed price purchase order contract was awarded by the Department of Veterans Affairs (VA) to Tempus AI, Inc. (Tempus Labs Inc.) to provide DNA methylation and genome-wide association services to evaluate changes in epigenetic aging for veterans with HIV who participated in a telehealth-delivered high-intensity exercise study. The contract has a ceiling value of $67,572.00 and a period of performance through September 29, 2025. There is no set-aside designation for this requirement....
The Department of Veterans Affairs (VA) awarded a $2,022,406 Firm Fixed Price Delivery Order contract to Tempus Labs Inc., doing business as Tempus, to provide Tumor Normal Matched Genomic Testing Services. Tempus will perform genomic testing services on tumor and normal tissue samples from VA patients to identify genomic variants that may be targeted for precision cancer therapies. The contract has a one-year period of performance starting January 28, 2022 through January 27, 2023 and will be...
This contract was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Akesogen, Inc.'s Tempus Labs division for DNA extraction services. The $5,286.10 firm-fixed-price purchase order does not have a set-aside designation. Tempus Labs is a for-profit technology company that specializes in advanced genomic analysis services, primarily supporting large-scale biomedical research programs conducted by federal agencies like the Department of...
Tempus Labs Inc. is providing tumor normal matched genomic testing services to the Department of Veterans Affairs (VA) under a $5,999,647 firm fixed price delivery order. This order was issued against an Indefinite Delivery contract held by Tempus with the VA worth up to $64 million for such services. Through January 2027, Tempus will analyze genomic sequencing data from veteran cancer patients' tumor and normal tissue samples to help inform precision medicine treatment decisions within the VA...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order to Tempus Labs Inc. (Tempus) to create breast cancer organoids for preclinical testing of tumor necrosis factor related apoptosis inducing ligand (TRAIL). The $135,000.00 purchase order was awarded on September 12, 2019 and has a completion date of September 11, 2022. Tempus is a technology company that provides genomic sequencing services and precision...
This is a $4,000,000.00 firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs Headquarters to Akesogen, Inc.'s Tempus Labs, Inc. division for genomic analysis services. The contract has a period of performance through July 21, 2025 and is not designated as a set-aside. Tempus Labs, a for-profit technology company, will provide genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular...
The Department of Veterans Affairs (VA) Headquarters awarded a firm fixed price delivery order contract to Akesogen, Inc.'s Tempus Labs, Inc. division, a for-profit technology company that provides genomic sequencing and analysis services. The $13,020,379.40 contract tasks Tempus Labs with conducting genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services to support the VA's biomedical research programs,...
The Department of Veterans Affairs Headquarters awarded Akesogen, Inc. Tempus Labs, Inc. Division, a for-profit organization, a Firm Fixed Price Delivery Order contract worth $9,874,980.00 to provide genomic analysis services. The contract, with a performance period ending March 20, 2024, tasks Tempus Labs with conducting genomic sequencing, DNA quality assessment, single nucleotide polymorphism genotyping, methylation analysis, and other molecular testing services at the VA Headquarters in...